BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7993114)

  • 1. [A basic and clinical study of CA 19-9-MP-Mitsui kit for determination of CA 19-9].
    Ishii M; Iida M; Seino Y
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2779-86. PubMed ID: 7993114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers].
    Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):2085-93. PubMed ID: 1417016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical investigation of carbohydrate antigen CA-50].
    Ishii M; Abe O; Okura H; Okazaki N; Kawai T; Saito Y; Sawabu N; Takamizawa Y; Takeuchi T; Niitani H
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2548-55. PubMed ID: 3304170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CA 19-9 enzyme immunoassay].
    Ota H; Odani H; Watanabe H; Satomura Y; Takemori Y; Okai T; Sawabu N; Mai M; Hattori N; Hashimoto T
    Gan No Rinsho; 1986 Aug; 32(9):993-7. PubMed ID: 3528560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (1)].
    Ohkura H; Hattori N; Miyazaki I; Sawabu N; Tobe R; Kawai K; Abe O; Ishii M; Kawai T; Kamano T
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1901-6. PubMed ID: 2439020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of CA 19-9 radioimmunoassay].
    Toya D; Takemori Y; Kidani H; Yoneshima M; Hattori N; Sawabu N
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):509-14. PubMed ID: 6584087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of CA 15-3 radioimmunoassay].
    Takemori Y; Odani H; Watanabe H; Ohta H; Satomura Y; Okai T; Sawabu N; Mai M; Hattori N; Hashimoto T
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):114-8. PubMed ID: 3467654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of serum DU-PAN-2 surveyed by solid-phase sandwich EIA for DU-PAN-2].
    Ishii M; Urabe T; Seino Y
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1860-5. PubMed ID: 3296960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity.
    Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Watanabe K; Magario N; Yokoo T; Naraki T
    Cancer; 1999 Feb; 85(4):812-8. PubMed ID: 10091758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum determination of CA 19-9 in patients with digestive cancers and its diagnostic evaluation].
    Arakawa Y; Kobayashi H; Ozaki T; Ariga H; Matsuo Y; Honda T; Arai T; Kurosu Y; Morita K; Konuma H
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):917-25. PubMed ID: 6586110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Basic and clinical studies on serum CEA levels using a new CEA-EIA (double monoclonal) kit].
    Ogoshi K; Mitomi T
    Gan No Rinsho; 1984 Dec; 30(15):1913-8. PubMed ID: 6396422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of TPA-assay kit using monoclonal antibodies].
    Saga T; Sakahara H; Kousaka T; Yao Z; Nakamoto Y; Hattori N; Zhang M; Nakayama M; Ohshio G; Imamura M; Konishi J
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):615-21. PubMed ID: 8678521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of preclinical and clinical usefulness of new tumor markers of ovarian carcinoma, CA 54/61 and CA 602. 1. Evaluation of the diagnostic accuracy of CA 54/61, a study of the normal range of its values and its correlation with other tumor markers].
    Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hasimoto M
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):827-35. PubMed ID: 1605661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (1) Clinical usefulness of BFP].
    Ishii M; Hattori N; Kato T; Mochizuki M; Kamidono S; Sawabu N; Kawada Y; Kawai T; Abe O; Ohkura H
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2107-13. PubMed ID: 2456039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (2) Comparison and combination of BFP with other tumor markers].
    Ishii M; Hattori N; Kato T; Mochizuki M; Kamidono S; Sawabu N; Kawada Y; Kawai T; Abe O; Ohkura H
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2115-23. PubMed ID: 2456040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma.
    Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Takasaki K; Takenami K; Yamamoto M; Nakano M
    Cancer; 2000 Feb; 88(3):544-9. PubMed ID: 10649245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
    Ozkan H; Kaya M; Cengiz A
    Hepatogastroenterology; 2003; 50(53):1669-74. PubMed ID: 14571813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Measurement of serum tissue polypeptide antigen (TPA) in patients with malignant tumor using prolifigen TPA-M "Daiichi" kit].
    Sakahara H; Endo K; Torizuka K; Itoh K; Ohuchi N; Inaba N; Miyaji Y; Takayama M; Ishii K; Takagi H; Konishi J; Fukuoka M; Fukuchi M; Ohkawa J; Kagawa S; Kondo S; Shirouzu K; Iguchi H
    Gan To Kagaku Ryoho; 1996 May; 23(6):733-43. PubMed ID: 8645025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
    Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E
    Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (first report)--preclinical study of GAT assay kit and clinical study of normal level].
    Nozawa S; Udagawa Y; Ito K; Susumu N; Sasaki H; Aoki D
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):271-7. PubMed ID: 8434966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.